Michael Borger
Latest contributions
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025
In this interview, Alex Sticchi speaks with Fabien Praz and Michael Borger, co-chairs of the 2025 ESC/EACTS Valvular Guidelines Task Force. They discuss the major updates, including the central role of multimodality imaging, the lowered age threshold for TAVI, the distinction between atrial and ventricular secondary...
TAVI in bicuspid: all you need to know
22 May 2025 – From EuroPCR 2025
Understand the unique anatomical and clinical challenges of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves. This session covers bicuspid valve epidemiology, indications for surgery and TAVI, and detailed discussion on sizing and deployment fundamentals specific to bicuspid anatomy to optimize procedural success.
TAVI and coronary artery disease
22 May 2025 – From EuroPCR 2025
Examine the evolving role of coronary artery disease assessment in TAVI patients. This session compares coronary tomography and angiography for pre-TAVI evaluation, reviews safety and effectiveness of CT angiography-based strategies, and introduces the UNICORN procedure for managing high coronary obstruction risk in complex TAVI scenarios including...
Hotline TAVI 1: extended analysis of the randomised trials
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.
How to build a tricuspid programme?
20 May 2025 – From EuroPCR 2025
Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.
How to achieve optimal results in tricuspid valve interventions?
15 May 2024 – From EuroPCR 2024
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
Contemporary surgical and transcatheter approaches for multivalve disease
21 Nov 2023 – From PCR London Valves 2023
Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session: gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...
TAVI - Durability and long-term outcomes
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn more about TAVI durability and long-term outcomes through a selection of abstracts: delve into a comprehensive five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis, navigate through the complexities of long-term outcomes associated with prosthesis-patient mismatch following valve-in-valve TAVI, explore...
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
TAVI in complex scenarios - Valve-in-valve TAVI (TAV-in-SAV) - A tailored approach
20 Nov 2023 – From PCR London Valves 2023
This session is designed for those seeking an understanding of critical imaging principles in planning successful TAV-in-SAV procedures. Gain insights into the latest tools for pre-procedural imaging and learn how to develop customized algorithms for selecting transcatheter heart valves in individual patients undergoing TAV-in-SAV interventions.
Valve in valve - TAVI in SAV - Part 1
20 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in TAVI in SAV with this selection of cases: learn how to manage a degenerated surgical valve using a novel transcatheter heart valve, navigate low-contrast valve-in-valve scenarios in early bioprosthesis failure, witness the adaptability of TAVI valve-in-valve in a severely tortuous and horizontal...
Management of tricuspid valve regurgitation
11 Dec 2022
Watch the replay of the 2nd webinar on Tricuspid valve disease: patient pathways. You’ll learn all about 'Management of tricuspid valve regurgitation'
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
Treatment of multi-valve disease
29 Nov 2022 – From PCR London Valves 2022
Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...
TAVI durability: important considerations for patient lifetime management
18 May 2022 – From EuroPCR 2022
TAVI in severe calcified anatomy
17 May 2022 – From EuroPCR 2022
Consult this session to discover some complex TAVI cases in severe calcified anatomy, such as: high-risk aortic stenosis patient treated with orbital atherectomy, IVL and TAVI, antegrade-retrograde technique in uncrossable aortic valve, TAVI in severe calcified bicuspid aortic valve with LV apical clot, and much more!
Aortic valve disease: guidelines and beyond
22 Nov 2021 – From PCR London Valves 2021
Through this PCR London Valves 2021 session, compare the new ESC aortic valve disease guidelines with the US guidelines, focus on controversies and uncertainties of these AVD guidelines, see how to apply the guidelines using the Heart Team decision-making concept, and appreciate in a live case...
Aortic stenosis in the younger patient: procedural complications and lifetime management
21 Nov 2021 – From PCR London Valves 2021
Biological, surgical valves and TAVIs are being implanted in younger and younger patients. Since these procedures must be planned in the best possible way to minimize future complications, and because the lifetime management of these patients must be thought of, watch this session to get very useful...
Transcatheter mitral valve replacement and repair: why do we need both
18 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Borger, Nicolas Dumonteil, Paolo Denti, Lenard Conradi, Hendrik Treed and Ralph von Bardeleben in order to learn about the expanded treatment options and latest innovations in transcatheter mitral valve therapies, and to tailor your treatment options to optimise patient outcomes with...
Innovations in surgical and transcatheter tricuspid valve intervention
24 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to hear more about the latest advances in surgical and transcatheter approaches to tricuspid valve disease, to appreciate the anatomical, clinical and engineering challenges associated with future development and to learn how the COVID 19 pandemic has impacted on progress...
Minimally invasive tricuspid valve repair and MAZE case from Leipzig Heart Center - Leipzig, Germany
24 Nov 2020 – From PCR Valves e-Course 2020
View this virtual LIVE case surgery recorded in Leipzig Heart Center, Germany – followed by LIVE call-ins from different city pods around the globe.
A 67-year-old low-risk active lady with severe tricuspid regurgitation, persistent atrial fibrillation with dilated atria and moderate RV dilatation but preserved RVEF.
This session...
Minimally invasive mitral valve repair case - Session with LIVE case
23 Nov 2020 – From PCR Valves e-Course
View this virtual LIVE case surgery recorded in Leipzig Heart Center, Germany – followed by LIVE call-ins from different city pods around the globe.
This session was originally presented during PCR Valves e-Course 2020.
Minimally invasive aortic valve and ascending aortic replacement case from Leipzig Heart Center - Leipzig, Germany - Session with LIVE case
22 Nov 2020 – From PCR Valves e-Course 2020
A 62-year-old active male with severe stenosis of bicuspid aortic valve, ascending aortic aneurysm and obesity…
View this virtual LIVE case surgery recorded in Leipzig Heart Center, Germany – followed by LIVE call-ins from different city pods around the globe.
This session was originally presented during PCR Valves...
Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in pure aortic regurgitation to learn more about the anatomy and pathophysiology of aortic regurgitation, the current and emerging surgical treatment options, and the potential role of TAVI in this patient group and how to identify potential candidates for transcatheter intervention.
Late-Breaking Trials at PCR London Valves 2019 - Session 2
18 Nov 2019 – From PCR London Valves 2019
View this session from PCR London Valves 2019 presenting late-breaking trials on incidence, predictors and outcome of structural valve deterioration in transcatheter vs. SAVR, and percutaneous edge-to-edge repair for tricuspid regurgitation.
TAVI device selection for severe aortic stenosis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from University Hospital of Zurich (Zurich, Switzerland) to learn more about TAVI device selection and « Best practice » implantation of the Portico Valve.
